Today's Globe: Biotech Council, bipolar boom, Ashby school, executive function
As the Massachusetts Biotechnology Council's new leader faces ethics questions, some members say they have become disenchanted with the trade group, including its increasing focus on lobbying, a high staff turnover rate, and the low number of top executives serving on its board.
The diagnosis of bipolar disorder in children and adolescents has risen fortyfold since 1994, according to a new study released yesterday. But researchers partly attributed the dramatic rise to doctors overdiagnosing the serious psychiatric disorder.
When Ashby Academy, a boarding school specializing in children with Asperger's syndrome, abruptly closed last week, it left families from around the country stunned and wondering where their children will attend school this year - or whether they will see their tuition money again.
If you've never heard of executive function, brace yourself. It's bursting onto the educational scene, Child Caring columnist Barbara F. Meltz writes.
This blogger might want to review your comment before posting it.
Contributors
blogger
Elizabeth Cooney covers health for the Worcester Telegram & Gazette. She
previously reported on business and was an editor at the paper. Earlier in
her career, she edited medical books and journals at Little, Brown, and
worked for Boston magazine.Boston Globe Health and Science staff:
- Karen Weintraub, Deputy Health and Science Editor
- Gideon Gil, Health and Science Editor
- Ishani Ganguli, Short White Coat blogger
- Joshua U. Klein, M.D., Short White Coat blogger






